The increased demand for plasma-derived factor VIII in Italy

被引:6
|
作者
Arcieri, Romano [1 ]
Calizzani, Gabriele [2 ]
Candura, Fabio [2 ]
Mannucci, Pier Mannuccio [3 ,4 ]
机构
[1] Natl Inst Hlth, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy
[2] Natl Inst Hlth, Italian Natl Blood Ctr, Rome, Italy
[3] IRCCS Ca Granda Fdn, Maggiore Hosp Policlin, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, Milan, Italy
[4] Univ Milan, Milan, Italy
关键词
HEMOPHILIA;
D O I
10.2450/2016.0156-16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:279 / 280
页数:2
相关论文
共 50 条
  • [1] Why plasma-derived factor VIII?
    Aledort, Louis
    Carpenter, Shannon L.
    Cuker, Adam
    Kulkarni, Roshni
    Recht, Michael
    Young, Guy
    Leissinger, Cindy
    HAEMOPHILIA, 2019, 25 (03) : E183 - E185
  • [2] Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2010, 8 (04) : 288 - 291
  • [3] Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
    Lin, Y
    Yang, X
    Chevrier, MC
    Craven, S
    Barrowcliffe, TW
    Lemieux, R
    Ofosu, FA
    HAEMOPHILIA, 2004, 10 (05) : 459 - 469
  • [4] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
    BRAY, G
    ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34
  • [5] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 45 - 46
  • [6] Viral safety of plasma-derived factor VIII and IX concentrates
    Ludlam, CA
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S19 - S23
  • [7] Plasma-derived versus recombinant factor VIII for the treatment of hemophilia A
    Kasper, CK
    VOX SANGUINIS, 1996, 70 : 17 - 20
  • [8] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
  • [9] Cellular Stress Induced by Plasma-Derived Factor VIII Products
    Brodde, Martin
    Mueller, Anja
    Kehrel, Beate
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 140 - 144
  • [10] Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
    Lai, Jesse
    Hough, Christine
    Tarrant, Julie
    Lillicrap, David
    BLOOD, 2017, 129 (24) : 3147 - 3154